SCHEMBL5566472

SCHEMBL5566472

Nc1c(C(O)(C(F)(F)F)C(F)(F)F)ccc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 1.00
MEN1 O00255 2/20 1.00
MAPT P10636 2/20 1.00
KMT2A Q03164 2/20 1.00
ALDH1A1 P00352 1/20 1.00
GLA P06280 1/20 1.00
POLB P06746 1/20 1.00
GAA P10253 1/20 1.00
HPGD P15428 1/20 1.00
ATM Q13315 1/20 1.00
HSD17B10 Q99714 1/20 1.00
LMNA P02545 1/20 0.62
MAPK1 P28482 1/20 0.62
HTT P42858 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
KCNJ11 Q14654 18/20 0.55
ABCC9 O60706 10/20 0.55
ABCC8 Q09428 10/20 0.55
KCNJ8 Q15842 10/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7258624 1.00 KDM4E (1.00) KDM4EMEN1MAPTKMT2AALDH1A1
Acetamide SCHEMBL7260906 0.91 KDM4E (0.82) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL7258623 0.87 KDM4E (0.76) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL10036538 0.81 KDM4E (0.69) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL4076480 0.81 HSD17B10 (0.68) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL3885735 0.81 KDM4E (0.68) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL2784215 0.81 KDM4E (0.68) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL2784620 0.81 MEN1 (0.67) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL14593291 0.80 KDM4E (0.66) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL2782869 0.80 KDM4E (0.67) KDM4EMEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003089404-A1 NAPHTHALENE AMIDES AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2003-10-30 WO claimed
US-20030199578-A1 Naphthalene amides as potassium channel openers ABBOTT LABORATORIES 2003-10-23 US claimed
US-20070166288-A1 Formulation to improve survival of transplanted cells UNIVERSITY OF WASHINGTON 2007-07-19 US disclosed
WO-2003089404-A1 NAPHTHALENE AMIDES AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2003-10-30 WO disclosed
US-20030199578-A1 Naphthalene amides as potassium channel openers ABBOTT LABORATORIES 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199578-A1 Naphthalene amides as potassium channel openers KCNJ2, KCNN2, KCNJ1 KDM4E 1005/4885MEN1 982/4885MAPT 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.